Annual EBITDA
$36.68 M
+$11.86 M+47.79%
December 31, 2023
Summary
- As of February 12, 2025, VMD annual EBITDA is $36.68 million, with the most recent change of +$11.86 million (+47.79%) on December 31, 2023.
- During the last 3 years, VMD annual EBITDA has risen by +$223.00 thousand (+0.61%).
- VMD annual EBITDA is now at all-time high.
Performance
VMD EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$12.13 M
+$2.75 M+29.34%
September 30, 2024
Summary
- As of February 12, 2025, VMD quarterly EBITDA is $12.13 million, with the most recent change of +$2.75 million (+29.34%) on September 30, 2024.
- Over the past year, VMD quarterly EBITDA has increased by +$1.68 million (+16.08%).
- VMD quarterly EBITDA is now -19.61% below its all-time high of $15.09 million, reached on June 30, 2020.
Performance
VMD Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$41.32 M
+$1.68 M+4.24%
September 30, 2024
Summary
- As of February 12, 2025, VMD TTM EBITDA is $41.32 million, with the most recent change of +$1.68 million (+4.24%) on September 30, 2024.
- Over the past year, VMD TTM EBITDA has increased by +$7.98 million (+23.94%).
- VMD TTM EBITDA is now at all-time high.
Performance
VMD TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
VMD EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +47.8% | +16.1% | +23.9% |
| 3 y3 years | +0.6% | +16.1% | +23.9% |
| 5 y5 years | +169.0% | +16.1% | +23.9% |
VMD EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +52.0% | at high | +162.0% | at high | +72.7% |
| 5 y | 5-year | at high | +136.5% | -19.6% | +191.6% | at high | +170.8% |
| alltime | all time | at high | +1876.1% | -19.6% | +1260.1% | at high | +1270.0% |
Viemed Healthcare EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $12.13 M(+29.3%) | $41.32 M(+4.2%) |
| Jun 2024 | - | $9.38 M(+9.6%) | $39.64 M(+3.0%) |
| Mar 2024 | - | $8.56 M(-24.0%) | $38.48 M(+5.1%) |
| Dec 2023 | $36.68 M(+47.8%) | $11.25 M(+7.7%) | $36.60 M(+9.8%) |
| Sep 2023 | - | $10.45 M(+27.1%) | $33.34 M(+16.7%) |
| Jun 2023 | - | $8.22 M(+23.2%) | $28.56 M(+14.4%) |
| Mar 2023 | - | $6.67 M(-16.5%) | $24.97 M(+4.4%) |
| Dec 2022 | $24.82 M(+2.8%) | $7.99 M(+40.8%) | $23.92 M(-1.1%) |
| Sep 2022 | - | $5.67 M(+22.5%) | $24.18 M(-1.8%) |
| Jun 2022 | - | $4.63 M(-17.8%) | $24.62 M(-3.8%) |
| Mar 2022 | - | $5.63 M(-31.7%) | $25.60 M(+6.1%) |
| Dec 2021 | $24.13 M(-33.8%) | $8.24 M(+34.8%) | $24.13 M(+0.4%) |
| Sep 2021 | - | $6.12 M(+9.0%) | $24.05 M(-1.5%) |
| Jun 2021 | - | $5.61 M(+34.8%) | $24.42 M(-28.0%) |
| Mar 2021 | - | $4.16 M(-49.0%) | $33.90 M(-4.0%) |
| Dec 2020 | $36.45 M | $8.16 M(+25.8%) | $35.31 M(+11.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $6.49 M(-57.0%) | $31.79 M(+8.4%) |
| Jun 2020 | - | $15.09 M(+170.6%) | $29.32 M(+69.3%) |
| Mar 2020 | - | $5.58 M(+20.2%) | $17.31 M(+13.5%) |
| Dec 2019 | $15.51 M(+13.8%) | $4.64 M(+15.6%) | $15.26 M(+6.5%) |
| Sep 2019 | - | $4.01 M(+30.0%) | $14.33 M(+3.9%) |
| Jun 2019 | - | $3.09 M(-12.4%) | $13.79 M(-1.7%) |
| Mar 2019 | - | $3.52 M(-5.1%) | $14.03 M(+2.9%) |
| Dec 2018 | $13.63 M(+23.9%) | $3.71 M(+7.0%) | $13.63 M(+26.1%) |
| Sep 2018 | - | $3.47 M(+4.3%) | $10.81 M(-10.2%) |
| Jun 2018 | - | $3.33 M(+6.3%) | $12.04 M(+8.3%) |
| Mar 2018 | - | $3.13 M(+250.8%) | $11.12 M(+1.0%) |
| Dec 2017 | $11.01 M(+493.0%) | $892.00 K(-81.0%) | $11.01 M(+8.8%) |
| Sep 2017 | - | $4.69 M(+94.8%) | $10.11 M(+86.5%) |
| Jun 2017 | - | $2.41 M(-20.2%) | $5.42 M(+79.8%) |
| Mar 2017 | - | $3.02 M | $3.02 M |
| Dec 2016 | $1.86 M | - | - |
FAQ
- What is Viemed Healthcare annual EBITDA?
- What is the all time high annual EBITDA for Viemed Healthcare?
- What is Viemed Healthcare annual EBITDA year-on-year change?
- What is Viemed Healthcare quarterly EBITDA?
- What is the all time high quarterly EBITDA for Viemed Healthcare?
- What is Viemed Healthcare quarterly EBITDA year-on-year change?
- What is Viemed Healthcare TTM EBITDA?
- What is the all time high TTM EBITDA for Viemed Healthcare?
- What is Viemed Healthcare TTM EBITDA year-on-year change?
What is Viemed Healthcare annual EBITDA?
The current annual EBITDA of VMD is $36.68 M
What is the all time high annual EBITDA for Viemed Healthcare?
Viemed Healthcare all-time high annual EBITDA is $36.68 M
What is Viemed Healthcare annual EBITDA year-on-year change?
Over the past year, VMD annual EBITDA has changed by +$11.86 M (+47.79%)
What is Viemed Healthcare quarterly EBITDA?
The current quarterly EBITDA of VMD is $12.13 M
What is the all time high quarterly EBITDA for Viemed Healthcare?
Viemed Healthcare all-time high quarterly EBITDA is $15.09 M
What is Viemed Healthcare quarterly EBITDA year-on-year change?
Over the past year, VMD quarterly EBITDA has changed by +$1.68 M (+16.08%)
What is Viemed Healthcare TTM EBITDA?
The current TTM EBITDA of VMD is $41.32 M
What is the all time high TTM EBITDA for Viemed Healthcare?
Viemed Healthcare all-time high TTM EBITDA is $41.32 M
What is Viemed Healthcare TTM EBITDA year-on-year change?
Over the past year, VMD TTM EBITDA has changed by +$7.98 M (+23.94%)